NCT06731504 2026-01-16
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
Duke University
Phase EARLY_PHASE1 Recruiting
Clinical Trials
7 trialsNCT06765876 2026-01-12
UHKT-CAR123-01
Institute of Hematology and Blood Transfusion, Czech Republic
Phase EARLY_PHASE1 Recruiting
NCT07131254 2025-12-30
A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors
Grit Biotechnology
Phase EARLY_PHASE1 Recruiting
NCT06184321 2025-12-26
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT04744116 2025-11-10
Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT03537482 2024-08-19
APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
Ascentage Pharma Group Inc.
Phase EARLY_PHASE1 Recruiting
NCT05707325 2024-07-24
Reboot-101
Westlake Therapeutics
Phase EARLY_PHASE1 Recruiting